Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for Nausea and Vomiting in Terminally Ill Patients
NCT00982995Phase 2Terminated
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Nov 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in nausea ((none)), Vomiting, sponsored by University of Michigan Rogel Cancer Center. Started Nov 2010; status: terminated.
02
Drugs
palonosetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT00982995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982995.